Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047277 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Nightmares in Children
A NA study of Nightmare, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT04047277: Completed NA study of Nightmare, sponsored by University of Oklahoma.
NCT04047277 is a NA study of Nightmare that has completed, run by University of Oklahoma. The registered enrollment target is 24 participants, below the 50-participant average among 8 other Nightmare trials with a reported enrollment target (52% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04047277, a NA study of Nightmare, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
Up to 50% of children experience nightmares annually. Nightmares interfere with sleep quality and quantity resulting in sleep deficiency, and are associated with negative mental health consequences. Previous research has shown efficacy of manualized CBT treatment for reducing trauma related nightmares in adults, and preliminary evidence has shown efficacy in children. This study is the first randomized clinical trial to evaluate the effectiveness of the treatment for idiopathic, as well as trauma related nightmares in children. The treatment in a manualized CBT protocol (5 sessions) that teaches sleep hygiene, relaxation strategies, and addresses nightmares therapeutically through exposure and rescripting.
Primary Outcome
The CATS screens for child trauma history and PTSD symptoms in youth ages 7-17; 15 YES/NO questions; 1 open-ended question
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Study Locations (2)
Oklahoma
- University of Tulsa - Tulsa
- University of Oklahoma School of Community Medicine - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
What the finished NCT04047277 record still lists
NCT04047277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 50-participant average among 8 other Nightmare trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Nightmare appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT04047277 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04047277 about?
NCT04047277 is a clinical study titled "Cognitive Behavioral Therapy for Nightmares in Children". Up to 50% of children experience nightmares annually. Nightmares interfere with sleep quality and quantity resulting in sleep deficiency, and are associated with negative mental health consequences. Previous research has shown efficacy of manualized CBT treatment for reducing trauma related nightmar...
What is the current status of trial NCT04047277?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-03-22. Estimated completion is 2020-10-30.
What conditions does trial NCT04047277 study?
This clinical trial studies the following conditions: Nightmare.
What interventions are being tested in trial NCT04047277?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04047277?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04047277 being conducted?
This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nightmare
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04047277's enrollment target sits among peer trials
24 7th of 8 higher than 2 of 8 other Nightmare trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nightmare trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NightWare and Cardiovascular Health in Veterans With PTSD
RECRUITING · NA
-
Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
RECRUITING · NA
-
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
RECRUITING · NA
-
Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy
COMPLETED · NA
-
NightWare and Cardiovascular Health in Adults With PTSD
COMPLETED · NA
-
Remote Study of NightWare for PTSD With Nightmares
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI